The most significant way to improve care of patients with complex regional pain syndrome is with an early diagnosis.
By Gary W. Jay, MD
Complex regional pain syndrome (CRPS) is a heterogeneous group of disorders that generally develop after trauma to soft tissue but also may develop after visceral diseases or nerve lesions, or rarely without an obvious antecedent event. This debilitating neurologic syndrome is characterized by pain and hypersensitivity, vasomotor skin changes, and functional impairment. Structural changes in both the deep and superficial tissues may occur.
The precise cause of the syndrome is not known, and treatments are not curative. However, emerging research is helping to further understanding of the pathogenesis and treatment of this challenging syndrome.
CRPS is grouped into 2 categories (CRPS type I and CRPS type II) based on the absence or presence, respectively, of peripheral nerve damage. The International Association for the Study of Pain (IASP) defines CRPS type I as “a syndrome that usually develops after an initiating noxious event, is not limited to the distribution of a single peripheral nerve, and is apparently disproportionate to the inciting event. It is associated at some point with evidence of edema, changes in skin blood flow, abnormal sudomotor activity in the region of the pain, or allodynia or hyperalgesia.”1 CRPS type II is characterized by clinical signs of peripheral nerve injury, such as abnormalities found on nerve conduction study.2
Signs and Symptoms
CRPS is a spectrum disorder with clinical features varying in intensity and clinical presentation. The symptoms and diagnostic features of CRPS types I and II are identical. They include severe pain or uncomfortable sensations, as well as limb swelling, hair growth changes (most typically hair falling out, as well as possible development of coarser, darker hair and/or rapid hair growth), nail changes (faster growth, distorted shape), as well as muscle atrophy, increased sweating, and skin changes (thin and shiny, or skin lesions).3 Symptoms may be acute or last for many years.
In addition, patients may experience a spreading of symptoms to other parts of the body—most commonly in a contralateral or ipsilateral pattern. Diagonal spread is rare but also may occur.4Spread of symptoms typically occurs spontaneously without a secondary trauma, except in the case of diagonal spread, which generally occurs in the context of a new trauma and is more common in patients with a younger age at onset of CRPS and a more severely affected phenotype.4 Although the cause of spreading CRPS symptoms is not clear, researchers have speculated that CRPS may spread by spinally or cortically mediated mechanisms.4
A recent study examining the clinical characteristics of patients with CRPS found that approximately 73% of CRPS patients were female, and the mean age at onset of symptoms was 43 years.5The investigators also found a greater predominance of left-handedness (21.8% vs 10% in the general population) and multiple limb involvement (13%, 83% of whom had contiguous spread). The median time from symptom onset to diagnosis was 6 months, but ranged up to 129 months.
Warm and Cold Subtypes
Bruehl et al recently provided evidence to support the concept of warm and cold subtypes of CRPS in an international, multicenter study.6 Their evaluation of the signs and symptoms of CRPS in 152 patients revealed a warm CRPS patient cluster characterized by a warm, red, edematous, and sweaty extremity, and a cold CRPS patient cluster characterized by a cold, blue, and less edematous extremity.
Median pain duration was significantly shorter in the warm subtype than in the cold subtype (4.7 vs 20 months; P < 0.001), but pain intensity was comparable.6 A measure of inflammation was significantly elevated in the warm subtype (P < 0.001), but this measure decreased significantly the first year after injury (P < 0.001). The investigators suggested that inflammatory mechanisms may contribute most prominently to the acute phase of the warm subtype but diminish over time.
Pain catastrophizing, depression, and anxiety are commonly found in patients with CRPS and are linked with poorer outcomes.7,8 Notably, patients are at high risk for suicidal ideation (74%), underscoring the need for psychiatric evaluation and early intervention for psychiatric disorders in the overall management of CRPS.9 (see Patient Advocacy for Complex Regional Pain Syndrome.)
Pathophysiology of CRPS
The origins of the disease remain largely unclear. CRPS most likely is developed and maintained by both the central and peripheral nervous system. Possible contributors to CRPS include:
- Ischemic reperfusion injury or oxidative stress10-13
- Peripheral and central sensitization14-18
- Altered sympathetic nervous system function or sympatho-afferent coupling19-23
- Nerve injury24-26
- Neurogenic inflammation and autoimmune dysfunction, including activated glial cells27-31
- Brain plasticity32-35
- Genetic and psychological factors/disuse36-40
The Role of Glial Cells
Over the past decade, research on CRPS has focused on the role of glial cell activation in the perpetuation of CRPS. Increased glial cell activation has been demonstrated in patients with CRPS.30,31In addition, data from animal studies supports the hypothesis that limb fracture triggers afferent C-fiber substance P release, which signals chronic neuroglial activation. That glial activation, in turn, may contribute to the ongoing central nociceptive sensitization in CRPS.41 Evidence suggests that microglial activation triggers proinflammatory responses—including release of cytokines—that leads to neuronal hyperexcitability, neurotoxicity, and chronic inflammation.42
This research has led to investigation of pharmacotherapies to block glial cell activation in CRPS, including use of low-dose naltrexone and minocycline.
Brain Imaging Findings
Brain imaging research had vastly improved our understanding of CRPS and has demonstrated that CRPS is associated with abnormal brain system morphology. These morphologic changes result in dysregulation of pain processing in motor, sensory, affective pain, and autonomic systems.
For example, a 2014 study by Barad et al illustrated that patients with CRPS have a decreased volume of gray matter in pain-related affect regions in the brain including the dorsal insula, left orbitofrontal cortex, and several areas of the cingulate cortex.32Patients also had a greater volume of gray matter in the bilateral dorsal putamen and right hypothalamus.
- Merskey H, Bogduk K, eds.Detailed descriptions of pain syndro In: Classification of Chronic Pain, 2nd ed. Seattle: IASP Press; 2002.
- Bruehl S. Complex regional pain syndrome. 2015;351:h2730.
- Harden RN, Bruehl S, Perez RS, et al. Validation of proposed diagnostic criteria (the “Budapest Criteria”) for complex regional pain syndrome.Pain. 2010;150(2):268-274.
- van Rijn MA, Marinus J, Putter H, Bosselaar SR, Moseley GL, van Hilten JJ. Spreading of complex regional pain syndrome: not a random process.J Neural Transm (Vienna). 2011;118(9):1301-1309.
- Shenker N, Goebel A, Rockett M, et al. Establishing the characteristics for patients with chronic complex regional pain syndrome: the value of the CRPS-UK Registry.Br J Pain. 2015;9(2):122-128.
- Bruehl S, Maihöfner C, Stanton-Hicks M, et al. Complex regional pain syndrome: evidence for warm and cold subtypes in a large prospective clinical sample. 2016;157(8):1674-1681.
- Bean DJ, Johnson MH, Heiss-Dunlop W, Lee AC, Kydd RR. Do psychological factors influence recovery from complex regional pain syndrome type 1? A prospective study.Pain. 2015;156(11):2310-2318.
- Bean DJ, Johnson MH, Kydd RR. Relationships between psychological factors, pain, and disability in complex regional pain syndrome and low back pain.Clin J Pain. 2014;30(8):647-653.
- Lee DH, Noh EC, Kim YC, et al. Risk factors for suicidal ideation among patients with complex regional pain syndrome.Psychiatry Investig. 2014;11(1):32-38.
- Coderre TJ, Bennett GJ. A hypothesis for the cause of complex regional pain syndrome-type I (reflex sympathetic dystrophy): pain due to deep tissue microvascular pathology.Pain Med, 2010;11:1224-1238.
- De Mos M, Laferrière A, Millecamps M, et al. Role of NFkappaB in an animal model of complex regional pain syndrome-type I (CRPS-I).J Pain. 2009;10:1161-1169.
- Ross-Huot MC, Laferrière A, Khorashadi M, et al. Glycemia-dependent nuclear factor κB activation contributes to mechanical allodynia in rats with chronic postischemia pain.Anesthesiology. 2013;119:687-697.
- Eisenberg E, Shtahl S, Geller R, et al. Serum and salivary oxidative analysis in complex regional pain syndrome.Pain. 2008;138:226-232.
- Ji RR, Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain.Neurobiol Dis. 2001;8:1-10.
- Sieweke N, Birklein F, Riedl B, et al. Patterns of hyperalgesia in complex regional pain syndrome.Pain. 1999;80:171-177.
- Eisenberg E, Chistyakov AV, Yudashkin M, et al. Evidence for cortical hyperexcitability of the affected limb representation area in CRPS: a psychophysical and transcranial magnetic stimulation study.Pain. 2005;113:99-105.
- Cheng JK, Ji RR. Intracellular signaling in primary sensory neurons and persistent pain.Neurochem Res. 2008;33:1970-1978.
- Couture R, Harrisson M, Vianna RM, et al. Kinin receptors in pain and inflammation. Eur J Pharmacol.2001;429:161-176.
- Drummond ES, Dawson LF, Finch PM, et al. Increased expression of cutaneous α1-adrenoceptors after chronic constriction injury in rats.J Pain. 2014;15:188-196.
- Drummond PD, Drummond ES, Dawson LF, et al. Upregulation of α1-adrenoceptors on cutaneous nerve fibres after partial sciatic nerve ligation and in complex regional pain syndrome type II. 2014;155:606-616.
- Jørum E, Ørstavik K, Schmidt R, et al. Catecholamine-induced excitation of nociceptors in sympathetically maintained pain. 2007;127:296-301.
- Drummond PD, Finch PM, Skipworth S, et al. Pain increases during sympathetic arousal in patients with complex regional pain syndrome.Neurol. 2001;57:1296-1303.
- Baron R, Schattschneider J, Binder A, et al. Relation between sympathetic vasoconstrictor activity and pain and hyperalgesia in complex regional pain syndromes: a case-control study.Lancet. 2002;359:1655-1660.
- Albrecht PJ, Hines S, Eisenberg E, et al. Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome.Pain. 2006;120(3):244-266.
- Oaklander AL, Rissmiller JG, Gelman LB, Zheng L, Chang Y, Gott R. Evidence of focal small-fiber axonal degeneration in complex regional pain syndrome-I (reflex sympathetic dystrophy).Pain. 2006;120(3):235-243.
- Kharkar S, Venkatesh YS, Grothusen JR, Rojas L, Schwartzman RJ. Skin biopsy in complex regional pain syndrome: case series and literature review.Pain Physician. 2012;15(3):255-266.
- Li WW, Guo TZ, Shi X, et al. Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome.Pain. 2014;155:2377-2389.
- Schinkel C, Scherens A, Köller M, et al. Systemic inflammatory mediators in post-traumatic complex regional pain syndrome (CRPS I)—longitudinal investigations and differences to control groups.Eur J Med Res. 2009;14:130-135.
- inflammatory and positive sensory signs associated with complex regional pain syndrome.Pain. 2014;155:299-308.
- Alexander GM, Perreault MJ, Reichenberger ER, Schwartzman RJ. Changes in immune and glial markers in the CSF of patients with complex regional pain syndrome.Brain Behav Immun. 2007;21(5):668-676.
- Del Valle L, Schwartzman RJ, Alexander G. Spinal cord histopathological alterations in a patient with longstanding complex regional pain syndrome.Brain Behav Immun. 2009;23(1):85-91.
- Barad MJ, Ueno T, Younger J, Chatterjee N, Mackey S. Complex regional pain syndrome is associated with structural abnormalities in pain-related regions of the human brain.J Pain. 2014;15(2):197-203.
- Di Pietro F, McAuley JH, Parkitny L, et al. Primary somatosensory cortex function in complex regional pain syndrome: a systematic review and meta-analysis.J Pain. 2013;14:1001-1018.
- Di Pietro F, Stanton TR, Moseley GL, et al. Interhemispheric somatosensory differences in chronic pain reflect abnormality of the healthy side.Hum Brain Mapp. 2015;36:508-518.
- Di Pietro F, McAuley JH, Parkitny L, et al. Primary motor cortex function in complex regional pain syndrome: a systematic review and meta-analysis.J Pain. 2013;14:1270-1288.
- Herlyn P, Müller-Hilke B, Wendt M, et al. Frequencies of polymorphisms in cytokines, neurotransmitters and adrenergic receptors in patients with complex regional pain syndrome type I after distal radial fracture.Clin J Pain. 2010;26:175-81.
- Van Rooijen DE, Roelen DL, Verduijn W, et al. Genetic HLA associations in complex regional pain syndrome with and without dystonia.J Pain. 2012;13:784-789.
- Bean DJ, Johnson MH, Kydd RR. Relationships between psychological factors, pain, and disability in complex regional pain syndrome and low back pain.Clin J Pain. 2014;30:647-653.
- Marinus J, Perez RS, van Eijs F, et al. The role of pain coping and kinesiophobia in patients with complex regional pain syndrome type 1 of the legs.Clin J Pain. 2013;29:563-569.
- Guo TZ, Wei T, Li WW, et al. Immobilization contributes to exaggerated neuropeptide signaling, inflammatory changes, and nociceptive sensitization after fracture in rats.J Pain. 2014;15:1033-1045.
- Li WW, Guo TZ, Shi X, et al. Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture.Neuroscience. 2015;310:73-90.
- Milligan ED, Watkins LR. Pathological and protective roles of glia in chronic pain.Nat Rev Neurosci. 2009;10(1):23-36.
- Perez RS, Zollinger PE, Dijkstra PU, et al; CRPS I task force. Evidence based guidelines for complex regional pain syndrome type 1.BMC Neurol. 2010;10:20.
- Harden RN, Oaklander AL, Burton AW, et al; Reflex Sympathetic Dystrophy Syndrome Association. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th ed.Pain Med. 2013;14(2):180-229.
- Turner-Stokes L, Goebel A; Guideline Development Group. Complex regional pain syndrome in adults: concise guidance.Clin Med. 2011;11:596-600.
- Birklein F, Schlereth T. [Current aspects of the therapy of complex regional pain syndrome.] 2013;84:1436-1444.
- McCormick ZL, Gagnon CM, Caldwell M, et al. Short-term functional, emotional, and pain outcomes of patients with complex regional pain syndrome treated in a comprehensive interdisciplinary pain management program.Pain Med. 2015;16(12):2357-2367.
- Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: A meta-analytic review.Pain. 1992;49:221–230.
- Guzmán J, Esmail R, Karjalainen K, et al. Multidisciplinary rehabilitation for chronic low back pain: Systematic review.BMJ. 2001;322:1511–1516.
- Smart KM, Wand BM, O’Connell NE. Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II.Cochrane Database Syst Rev. 2016 Feb 24;2:CD010853.
- O’Connell NE, Wand BM, McAuley J, Marston L, Moseley GL. Interventions for treating pain and disability in adults with complex regional pain syndrome.Cochrane Database Syst Rev. 2013;4:CD009416.
- Topcuoglu A, Gokkaya NK, Ucan H, Karakuş D.The effect of upper-extremity aerobic exercise on complex regional pain syndrome type I: a randomized controlled study on subacute stroke.Top Stroke Rehabil. 2015;22(4):253-261.
- Oerlemans HM, Oostendorp RA, de Boo T, van der Laan L, Severens JL, Goris JA. Adjuvant physical therapy versus occupational therapy in patients with reflex sympathetic dystrophy/complex regional pain syndrome type I.Arch Phys Med Rehabil. 2000;81(1):49-56.
- Cossins L, Okell RW, Cameron H, Simpson B, Poole HM, Goebel A. Treatment of complex regional pain syndrome in adults: a systematic review of randomized controlled trials published from June 2000 to February 2012.Eur J Pain. 2013;17(2):158-173.
- Bruehl S, Chung OY. Psychological and behavioral aspects of complex regional pain syndrome management.Clin J Pain. 2006;22(5):430-437.
- den Hollander M, Goossens M, de Jong J, et al. Expose or protect? A randomized controlled trial of exposure in vivo vs pain-contingent treatment as usual in patients with complex regional pain syndrome type 1.Pain. 2016;157(10):2318-2329.
- van de Vusse AC, Stomp-van den Berg SG, Kessels AH, Weber WE. Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379].BMC Neurol. 2004;4:13.
- Adami S, Fossaluzza V, Gatti D, Fracassi E, Braga V. Bisphosphonate therapy of reflex sympathetic dystrophy syndrome.Ann Rheum Dis. 1997;56(3):201-204.
- Varenna M, Adami S, Rossini M, et al. Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study.Rheumatology (Oxford). 2013;52(3):534-542.
- Varenna M, Zucchi F, Ghiringhelli D, et al. Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double-blind, placebo-controlled study.J Rheumatol. 2000;27(6):1477-1483.
- Robinson JN, Sandom J, Chapman PT. Efficacy of pamidronate in complex regional pain syndrome type I.Pain Med. 2004;5(3):276-280.
- Manicourt DH, Brasseur JP, Boutsen Y, Depreseux G, Devogelaer JP. Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity.Arthritis Rheum. 2004;50(11):3690-3697.
- Goebel A, Baranowski A, Maurer K, Ghiai A, McCabe C, Ambler G. Intravenous immunoglobulin treatment of the complex regional pain syndrome: a randomized trial.Ann Intern Med. 2010;152(3):152-158.
- Goebel A, Shenker N, Padfield N, et al. Low-dose intravenous immunoglobulin treatment for complex regional pain syndrome (LIPS): study protocol for a randomized controlled trial.Trials. 2014;15:404.
- van Rijn MA, Munts AG, Marinus J, et al. Intrathecal baclofen for dystonia of complex regional pain syndrome. 2009;143(1-2):41-47.
- Younger J, Noor N, McCue R, Mackey S. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.Arthritis Rheum. 2013;65(2):529-538.
- gov. Low-dose naltrexone for the treatment of complex regional pain syndrome (LDN-CRPS). https://clinicaltrials.gov/ct2/show/NCT02502162?term=crps&rank=15. Accessed November 21, 2016.
- Sigtermans MJ, van Hilten JJ, Bauer MC, et al. Ketamine produces effective and long-term pain relief in patients with complex regional pain syndrome type 1. 2009;145(3):304-311.
- Schwartzman RJ, Alexander GM, Grothusen JR, Paylor T, Reichenberger E, Perreault M. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. 2009;147(1-3):107-115.
- Koffler SP, Hampstead BM, Irani F, et al. The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome.Arch Clin Neuropsychol. 2007;22(6):719-729.
- Kiefer RT, Rohr P, Ploppa A, et al. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study.Pain Med. 2008;9(8):1173-1201.
- Finch PM, Knudsen L, Drummond PD. Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine. 2009;146(1-2):18-25.
- Kalita J, Vajpayee A, Misra UK. Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial. 2006;99(2):89-95.
- Perez RS, Zuurmond WW, Bezemer PD, et al. The treatment of complex regional pain syndrome type I with free radical scavengers: a randomized controlled study.Pain. 2003;102(3):297-307.
- Groeneweg G, Huygen FJ, Niehof SP, et al. Effect of tadalafil on blood flow, pain, and function in chronic cold complex regional pain syndrome: a randomized controlled trial.BMC Musculoskelet Disord. 2008;9:143.
- Harke H, Gretenkort P, Ladleif HU, Rahman S, Harke O. The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study.Anesth Analg. 2001;92(2):488-495.
- Calderón E, Calderón-Seoane ME, García-Hernández R, Torres LM. 5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions.J Pain Res. 2016;9:763-770.
- Levy R, Deer T.A prospective, randomized, multi-center controlled clinical trial to assess the safety and efficacy of the Spinal Modulation Axium™ Neurostimulator System in the treatment of chronic pain. Presented at: the meeting of the North American Neuromodulation Society (NANS), December 2015, Las Vegas, NV.
- gov.TARGET Post-Approval Study (TARGET PAS). https://clinicaltrials.gov/ct2/show/NCT02800863?term=drg&rank=1. Accessed November 21, 2016.
- Visnjevac O, Costandi S, Patel BA, et al. A comprehensive outcome-specific review of the use of spinal cord stimulation for complex regional pain syndrome.Pain Pract. 2016 Oct 14. doi: 10.1111/papr.12513. [Epub ahead of print]
- Kemler MA, De Vet HC, Barendse GA, Van Den Wildenberg FA, Van Kleef M. The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: two years’ follow-up of the randomized controlled trial.Ann Neurol. 2004;55(1):13-18.
- Kemler MA, de Vet HC, Barendse GA, van den Wildenberg FA, van Kleef M. Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. J Neurosurg. 2008;108(2):292-298.
- O’Connell NE, Wand BM, Gibson W, Carr DB, Birklein F, Stanton TR. Local anaesthetic sympathetic blockade for complex regional pain syndrome.Cochrane Database Syst Rev. 2016;7:CD004598.
- Rocha Ride O, Teixeira MJ, Yeng LT, et al. Thoracic sympathetic block for the treatment of complex regional pain syndrome type I: a double-blind randomized controlled study.Pain. 2014;155(11):2274-2281
- Zollinger PE, Tuinebreijer WE, Breederveld RS, Kreis RW. Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures? A randomized, controlled, multicenter dose-response study.J Bone Joint Surg Am. 2007;89(7):1424-1431.
- Zollinger PE, Tuinebreijer WE, Kreis RW, Breederveld RS. Effect of vitamin C on frequency of reflex sympathetic dystrophy in wrist fractures: a randomized trial. 1999;354(9195):2025-2028.
- Besse JL, Gadeyne S, Galand-Desmé S, Lerat JL, Moyen B. Effect of vitamin C on prevention of complex regional pain syndrome type I in foot and ankle surgery.Foot Ankle Surg. 2009;15(4):179-182.
- Ekrol I, Duckworth AD, Ralston SH, Court-Brown CM, McQueen MM. The influence of vitamin C on the outcome of distal radial fractures: a double-blind, randomized controlled trial.J Bone Joint Surg Am. 2014;96(17):1451-1459.
- Meena S, Sharma P, Gangary SK, Chowdhury B. Role of vitamin C in prevention of complex regional pain syndrome after distal radius fractures: a meta-analysis.Eur J Orthop Surg Traumatol. 2015;25(4):637-641.
- Evaniew N, McCarthy C, Kleinlugtenbelt YV, Ghert M, Bhandari M. Vitamin C to prevent complex regional pain syndrome in patients with distal radius fractures: a meta-analysis of randomized controlled trials.J Orthop Trauma. 2015;29(8):e235-41.